Genetic screening for embryos in egg donation
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This trial tests a non-invasive genetic screening method for embryos to check for chromosomal abnormalities. It aims to improve pregnancy outcomes for women who receive donated eggs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 50 years old and are receiving donor eggs
- You agree to transfer only one embryo (at the blastocyst stage)
- Your male partner has normal sperm chromosome testing (FISH)
- You sign a consent form
- Neither you nor your partner have uterine abnormalities or abnormal chromosome tests
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for women aged 35–40 doing IVF. It compares genetic testing of embryos before transfer to standard care, to see if it improves pregnancy success.
This trial tests whether checking embryos for extra or missing chromosomes (aneuploidy) before transfer improves IVF success for women aged 37-41. You may be eligible if you have a partner or are using donor sperm and have normal ovarian reserve.
This study looks at using embryo genetic testing before pregnancy in IVF for women aged 35 to 40. It may help by identifying which embryos are more likely to lead to a healthy pregnancy, though you would still be screened to confirm you fit the criteria.
This study tests whether adding a non-invasive genetic test (called NiPGT-A) on the fluid around the embryo can improve success rates for women under 35 who have good-quality embryos. It focuses on the first or second IVF cycle with a single frozen embryo transfer.
This study looks at DNA found in leftover IVF lab materials to see if it can provide useful information during embryo screening. You might benefit indirectly by helping researchers test a less wasteful way to learn about embryos during IVF with chromosomal screening.
This study looks at a DNA-testing approach that uses material from an embryo’s environment to help screen embryos during IVF. You might be able to participate if you’re already planning IVF and choosing this specific LifeView testing.
Hear when a new IVF trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.